Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.55 USD
Change Today -0.11 / -0.18%
Volume 3.4M
TEVA On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
Tel Aviv
Frankfurt
As of 8:04 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Moshe Manor

Former Chief Executive Officer of Teva Asia & Pacific and President of Teva Asia & Pacific, Teva Pharmaceutical Industries Limited
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
59$313,028

Background*

Mr. Moshe Manor has been Chief Executive Officer and President of Protalix BioTherapeutics, Inc. since November 1, 2014. Mr. Manor served as the Chief Executive Officer and President for Teva Asia & Pacific at Teva Pharmaceutical Industries Limited. Mr. Manor served as President of Asia Region at Teva Pharmaceutical Industries Ltd. since August 2010 and served as Group Vice President of Global Branded Products from January 2009 to August 2010. Mr. Manor has served in ...

Read Full Background

Corporate Headquarters*

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships*

Chief Executive Officer, President and Director

Education*

BA 1982
Hebrew University of Jerusalem
MBA 1985
Tel Aviv University

Other Affiliations*

Annual Compensation*

Salary$93,667
Total Annual Compensation$93,667

Stock Options*

All Other Compensation$18,399
Exercisable Options56,250
Unexercisable Options843,750
Total Number of Options900,000

Total Compensation*

Total Annual Cash Compensation$112,066
Total Short Term Compensation$93,667
Other Long Term Compensation$18,399
Total Calculated Compensation$313,028
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $61.55 USD -0.11

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.